Literature DB >> 35121866

A therapy PUSh for GBM.

Virginia Morón-Calvente1,2, Sandra Blanco3,4.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 35121866     DOI： 10.1038/s43018-021-00255-z

Source DB:  PubMed          Journal:  Nat Cancer        ISSN： 2662-1347


× No keyword cloud information.
  11 in total

1.  Evaluation of salivary metabolomics in oral leukoplakia and oral squamous cell carcinoma.

Authors:  Gokul Sridharan; Pratibha Ramani; Sangeeta Patankar; Rajagopalan Vijayaraghavan
Journal:  J Oral Pathol Med       Date:  2019-02-18       Impact factor: 4.253

2.  X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions.

Authors:  N S Heiss; S W Knight; T J Vulliamy; S M Klauck; S Wiemann; P J Mason; A Poustka; I Dokal
Journal:  Nat Genet       Date:  1998-05       Impact factor: 38.330

3.  Pseudouridylation of tRNA-Derived Fragments Steers Translational Control in Stem Cells.

Authors:  Nicola Guzzi; Maciej Cieśla; Phuong Cao Thi Ngoc; Stefan Lang; Sonali Arora; Marios Dimitriou; Kristyna Pimková; Mikael N E Sommarin; Roberto Munita; Michal Lubas; Yiting Lim; Kazuki Okuyama; Shamit Soneji; Göran Karlsson; Jenny Hansson; Göran Jönsson; Anders H Lund; Mikael Sigvardsson; Eva Hellström-Lindberg; Andrew C Hsieh; Cristian Bellodi
Journal:  Cell       Date:  2018-04-05       Impact factor: 41.582

Review 4.  Non-genetic mechanisms of therapeutic resistance in cancer.

Authors:  Jean-Christophe Marine; Sarah-Jane Dawson; Mark A Dawson
Journal:  Nat Rev Cancer       Date:  2020-10-08       Impact factor: 60.716

Review 5.  Pseudouridine: still mysterious, but never a fake (uridine)!

Authors:  Felix Spenkuch; Yuri Motorin; Mark Helm
Journal:  RNA Biol       Date:  2014       Impact factor: 4.652

6.  A Prospective Analysis of Circulating Plasma Metabolites Associated with Ovarian Cancer Risk.

Authors:  Clary B Clish; Shelley S Tworoger; Oana A Zeleznik; A Heather Eliassen; Peter Kraft; Elizabeth M Poole; Bernard A Rosner; Sarah Jeanfavre; Amy A Deik; Kevin Bullock; Daniel S Hitchcock; Julian Avila-Pacheco
Journal:  Cancer Res       Date:  2020-01-22       Impact factor: 12.701

7.  Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia.

Authors:  Eliza Yankova; Wesley Blackaby; Mark Albertella; Justyna Rak; Etienne De Braekeleer; Georgia Tsagkogeorga; Ewa S Pilka; Demetrios Aspris; Dan Leggate; Alan G Hendrick; Natalie A Webster; Byron Andrews; Richard Fosbeary; Patrick Guest; Nerea Irigoyen; Maria Eleftheriou; Malgorzata Gozdecka; Joao M L Dias; Andrew J Bannister; Binje Vick; Irmela Jeremias; George S Vassiliou; Oliver Rausch; Konstantinos Tzelepis; Tony Kouzarides
Journal:  Nature       Date:  2021-04-26       Impact factor: 69.504

Review 8.  Cancer stem cells in glioblastoma.

Authors:  Justin D Lathia; Stephen C Mack; Erin E Mulkearns-Hubert; Claudia L L Valentim; Jeremy N Rich
Journal:  Genes Dev       Date:  2015-06-15       Impact factor: 11.361

Review 9.  The role of m6A, m5C and Ψ RNA modifications in cancer: Novel therapeutic opportunities.

Authors:  Paz Nombela; Borja Miguel-López; Sandra Blanco
Journal:  Mol Cancer       Date:  2021-01-18       Impact factor: 27.401

10.  R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m6A/MYC/CEBPA Signaling.

Authors:  Rui Su; Lei Dong; Chenying Li; Sigrid Nachtergaele; Mark Wunderlich; Ying Qing; Xiaolan Deng; Yungui Wang; Xiaocheng Weng; Chao Hu; Mengxia Yu; Jennifer Skibbe; Qing Dai; Dongling Zou; Tong Wu; Kangkang Yu; Hengyou Weng; Huilin Huang; Kyle Ferchen; Xi Qin; Bin Zhang; Jun Qi; Atsuo T Sasaki; David R Plas; James E Bradner; Minjie Wei; Guido Marcucci; Xi Jiang; James C Mulloy; Jie Jin; Chuan He; Jianjun Chen
Journal:  Cell       Date:  2017-12-14       Impact factor: 66.850
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.